Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2731983 | The Journal of Pain | 2015 | 12 Pages |
Abstract
This small, short-term, placebo-controlled trial of inhaled cannabis demonstrated a dose-dependent reduction in diabetic peripheral neuropathy pain in patients with treatment-refractory pain. This adds preliminary evidence to support further research on the efficacy of the cannabinoids in neuropathic pain.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Mark S. Wallace, Thomas D. Marcotte, Anya Umlauf, Ben Gouaux, Joseph H. Atkinson,